Literature DB >> 20858622

Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy.

K L Winthrop, D E Furst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20858622     DOI： 10.1136/ard.2010.133843

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

Review 1.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

Review 2.  In the Real World: Infections Associated with Biologic and Small Molecule Therapies in Psoriatic Arthritis and Psoriasis.

Authors:  Sarah A R Siegel; Kevin L Winthrop
Journal:  Curr Rheumatol Rep       Date:  2019-06-06       Impact factor: 4.592

Review 3.  The emerging safety profile of JAK inhibitors in rheumatic disease.

Authors:  Kevin L Winthrop
Journal:  Nat Rev Rheumatol       Date:  2017-03-02       Impact factor: 20.543

Review 4.  Adverse reactions to biologic agents and their medical management.

Authors:  Onur Boyman; Denis Comte; François Spertini
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

Review 5.  Vaccinations for rheumatoid arthritis.

Authors:  Lisa M Perry; Kevin L Winthrop; Jeffrey R Curtis
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

Review 6.  [Intracellular targets : current data on effectiveness and safety profile].

Authors:  R Alten
Journal:  Z Rheumatol       Date:  2013-11       Impact factor: 1.372

7.  Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.

Authors:  Kevin L Winthrop; John W Baddley; Lang Chen; Liyan Liu; Carlos G Grijalva; Elizabeth Delzell; Timothy Beukelman; Nivedita M Patkar; Fenglong Xie; Kenneth G Saag; Lisa J Herrinton; Daniel H Solomon; James D Lewis; Jeffrey R Curtis
Journal:  JAMA       Date:  2013-03-06       Impact factor: 56.272

8.  Increased risk of herpes zoster in patients with psoriasis: A population-based retrospective cohort study.

Authors:  Shin-Yi Tsai; Hsuan-Ju Chen; Chon-Fu Lio; Hui-Ping Ho; Chien-Feng Kuo; Xiaofeng Jia; Chi Chen; Yu-Tien Chen; Yi-Ting Chou; Tse-Yen Yang; Fang-Ju Sun; Leiyu Shi
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

9.  Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib.

Authors:  Kevin L Winthrop; Ann Wouters; Ernest H Choy; Connie Chen; Pinaki Biswas; Lisy Wang; Koshika Soma; Elie Needle; Hernan Valdez; William Fc Rigby
Journal:  Ann Rheum Dis       Date:  2020-03-11       Impact factor: 19.103

10.  Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis.

Authors:  Kevin L Winthrop; Hisashi Yamanaka; Hernan Valdez; Eric Mortensen; Robert Chew; Sriram Krishnaswami; Thomas Kawabata; Richard Riese
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.